This is a StreetInsider.com Premium Only Page

Avanir Pharma (AVNR) –

Feb 13, 2019 08:00 AM Avanir Pharmaceuticals, Inc. Reaches Agreement in Principle with U.S. Department of Justice Regarding NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) 20mg/10mg capsules

Jan 28, 2019 04:01 PM Insulet Appoints Corinne Nevinny to Board of Directors

Apr 19, 2017 10:00 AM Avanir Pharmaceuticals to Present Data on NUEDEXTA® and ONZETRA® Xsail® at American Academy of Neurology (AAN) 2017 Annual Meeting

Nov 29, 2016 12:00 PM Avanir Pharmaceuticals Appoints Richard Malamut, MD, as Senior Vice President, Research & Development, and Chief Medical Officer

Jun 9, 2016 05:30 PM Avanir Pharmaceuticals to Present Data on ONZETRA™ Xsail™ at American Headache Society (AHS) 2016 Annual Scientific Meeting

Jun 8, 2016 08:00 PM NUEDEXTA® Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury

May 16, 2016 09:02 AM Avanir Pharma (AVNR) Launches ONZETRA Xsail in the U.S.

May 16, 2016 09:00 AM AVANIR Pharmaceuticals Announces U.S. Launch and Availability of ONZETRA™ Xsail™ for the Acute Treatment of Migraine in Adults

Apr 15, 2016 05:19 PM Avanir Pharmaceuticals to Present Data on NUEDEXTA® and ONZETRA™ Xsail™ at American Academy of Neurology (AAN) 2016 Annual Meeting

Mar 30, 2016 09:00 AM MC10, Inc. Appoints Eric K. Brandt to its Board of Directors

Jan 28, 2016 05:16 PM Avanir Pharma (AVNR) Reports FDA Approval of ONZETRA to Treat Migraine

Jan 28, 2016 05:13 PM Avanir Pharmaceuticals Announces FDA Approval of ONZETRA™ Xsail™ (AVP-825) for the Acute Treatment of Migraine in Adults

Jan 20, 2016 08:30 AM Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as President and Chief Executive Officer

Dec 1, 2015 08:35 AM Avanir Pharma (AVNR) Announces Publication of PBA Data in IJGP

Dec 1, 2015 08:30 AM Avanir Pharmaceuticals Announces Publication of Study Evaluating the Prevalence of Pseudobulbar Affect (PBA) Symptoms and Use of Antipsychotic Medications in Nursing Homes

Nov 16, 2015 08:07 AM Concert Pharma (CNCE) Announces Receipt of Milestone Payment Tied to AVP-786 Development

Nov 16, 2015 08:00 AM Avanir Pharmaceuticals Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients with Alzheimer's Disease

Sep 22, 2015 11:51 AM Avanir Pharma (AVNR) Announces Publication of Statistically Significant AVP-923 Phase 2 Data in Alzheimer's Disease

Sep 22, 2015 11:49 AM Avanir Pharmaceuticals Announces JAMA Publication of Phase II Study Results Showing AVP-923 Significantly Reduced Agitation in Patients with Alzheimer's Disease

Aug 11, 2015 08:34 AM Avanir Pharma (AVNR) Announcs Favorable Appeals Court Decision in NUEDEXTA Case

Aug 11, 2015 08:30 AM Avanir Pharmaceuticals Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026

Jul 23, 2015 08:37 AM Avanir Pharma (AVNR) Announces Data from Alzheimer's Disease Cohort of PRISM II Study at AAIC

Jul 23, 2015 08:30 AM Avanir Pharmaceuticals Announces New Findings from Dementia/Alzheimer's Disease Cohort of PRISM II Study at Alzheimer's Association International Conference

Jun 30, 2015 09:00 AM /C O R R E C T I O N -- Avanir Pharmaceuticals, Inc./

Jun 30, 2015 09:00 AM Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study

Jun 17, 2015 09:02 AM Avanir Pharma (AVNR) Announces Publication of Significant AVP-825 Phase 3b Cross-Over Data in Migraine Pain Relief

Jun 17, 2015 09:00 AM Avanir Pharmaceuticals Announces Publication of Positive Phase IIIb Results from AVP-825 Head-to-Head COMPASS Study in the Journal "Headache"

May 18, 2015 10:10 AM Roth Remains Positive on Concert Pharma (CNCE) Amid Upcoming AVP-786 Phase 3s (AVNR)

May 5, 2015 09:00 AM Avanir Pharmaceuticals Announces Presentation of Survey Evaluating the Prevalence of Pseudobulbar Affect (PBA) Symptoms in Retired Professional Football Players at the 12th Annual North American Brain

May 1, 2015 09:00 AM Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition

Apr 15, 2015 09:55 AM Avanir Pharmaceuticals Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise at the American Academy of Neurology (AAN) 2015 Annual Meeting

Feb 17, 2015 01:17 PM Cooperman's Omega Advisors Adds to eBay (EBAY), Groupon (GRPN); Lowers Apple (AAPL); Liquidates Alibaba (BABA) (more...)

Jan 13, 2015 09:27 AM Form 8-K AVANIR PHARMACEUTICALS, For: Jan 13

Jan 13, 2015 08:21 AM Avanir Pharma (AVNR) trading halted with news pending

Jan 12, 2015 09:58 AM Form SC 13G/A AVANIR PHARMACEUTICALS, Filed by: FMR LLC

Dec 22, 2014 08:08 PM Form 4 AVANIR PHARMACEUTICALS, For: Dec 18 Filed by: Siffert Joao MD

Dec 18, 2014 08:55 PM Form 4 AVANIR PHARMACEUTICALS, For: Dec 16 Filed by: OCAMPO CHRISTINE

Dec 18, 2014 08:53 AM Form 4 AVANIR PHARMACEUTICALS, For: Dec 15 Filed by: Katkin Keith

Dec 15, 2014 07:57 AM Cowen Downgrades Avanir Pharmaceuticals (AVNR) to Market Perform

Dec 10, 2014 05:30 PM Form 10-K AVANIR PHARMACEUTICALS, For: Sep 30

Dec 3, 2014 02:24 PM Deutsche Bank Downgrades Avanir Pharmaceuticals (AVNR) to Hold

Dec 3, 2014 07:58 AM Mizuho Securities Downgrades Avanir Pharmaceuticals (AVNR) to Neutral

Dec 2, 2014 05:10 PM Market Wrap: RadioShack Hit on Investor Allegations; Aviva's Big Deal; Construction Spending Gains in Nov.;

Dec 2, 2014 12:46 PM Avanir (AVNR) Should Have Gotten at Least $26/Share in Takeover - Jefferies

Dec 2, 2014 10:07 AM Notable Mergers and Acquisitions of the Day 12/2: (AV) (AVNR) (GLW)

Dec 2, 2014 09:30 AM Pre-Open Stock Movers 12/02: (VGGL) (CODE) (AVNR) Higher; (VNCE) (AER) (DOV) Lower (more...)

Dec 2, 2014 09:16 AM Form 8-K AVANIR PHARMACEUTICALS, For: Dec 01

Dec 2, 2014 05:57 AM Otsuka Pharma to Acquire Avanir Pharma (AVNR) in $3.5B Deal

Nov 28, 2014 09:00 PM Form 4 AVANIR PHARMACEUTICALS, For: Nov 28 Filed by: PALEKAR ROHAN

Nov 28, 2014 06:10 AM Form 8-K AVANIR PHARMACEUTICALS, For: Nov 26